Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation (vol 106, pg 3285, 2005)

被引：0
|
作者：
Hubbard
机构：
来源：
BLOOD | 2006年 / 107卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：38 / 38
页数：1
相关论文
共 48 条
  • [1] Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation
    Hubbard, VM
    Eng, JM
    Ramirez-Montagut, T
    Tjoe, KH
    Muriglan, SJ
    Kochman, AA
    Terwey, TH
    Willis, LM
    Schiro, R
    Heller, G
    Murphy, GF
    Liu, C
    Alpdogan, O
    van den Brink, MRM
    BLOOD, 2005, 106 (09) : 3285 - 3292
  • [2] Absence of inducible costimulator on alloreactive T cells reduces graft-versus-host-disease while leaving graft-versus-tumor activity intact
    Tjoe, KH
    Eng, JM
    Alpdogan, O
    Muriglan, SJ
    Hubbard, VM
    Kochman, AA
    Schiro, R
    van den Brink, MRM
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 50 - 51
  • [3] Absence of inducible costimulator (ICOS) on alloreactive T cells reduces graft-versus-host-disease while leaving graft-versus-tumor activity intact.
    Hubbard, VM
    Eng, JM
    Tjoe, KH
    Ramirez-Montagut, T
    Muriglan, SJ
    Kochman, AA
    Terwey, TH
    Schiro, R
    Alpdogan, O
    van den Brink, MRM
    BLOOD, 2004, 104 (11) : 171A - 171A
  • [4] Photochemotherapy Induces a Faster Apoptosis of Alloreactive Activated T Cells Than of Nonalloreactive Resting T Cells in Graft Versus Host Disease
    Hannani, Dalil
    Merlin, Etienne
    Gabert, Francoise
    Laurin, David
    Demeocq, Francois
    Chaperot, Laurence
    Kanold, Justyna
    Plumas, Joel
    TRANSPLANTATION, 2010, 90 (11) : 1232 - 1238
  • [5] Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM)
    Taylor, PA
    Panoskaltsis-Mortari, A
    Freeman, GJ
    Sharpe, AH
    Noelle, RJ
    Rudensky, AY
    Mak, TW
    Serody, JS
    Blazar, BR
    BLOOD, 2005, 105 (08) : 3372 - 3380
  • [6] Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease (vol 10, pg 510, 2004)
    Merad, M
    Hoffmann, P
    Ranheim, E
    Slaymaker, S
    Manz, MG
    Lira, SA
    Charo, I
    Cook, DN
    Weissman, IL
    Strober, S
    Engleman, EG
    NATURE MEDICINE, 2004, 10 (06) : 649 - 649
  • [7] Absence of β7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine
    Waldman, E
    Lu, SX
    Hubbard, VM
    Kochman, AA
    Eng, JM
    Terwey, TH
    Muriglan, SJ
    Kim, TD
    Heller, G
    Murphy, GF
    Liu, C
    Alpdogan, O
    van den Brink, MRM
    BLOOD, 2006, 107 (04) : 1703 - 1711
  • [8] Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice
    Huang, Qingrong
    He, Shan
    Tian, Yuanyuan
    Gu, Yuting
    Chen, Pan
    Li, Changhong
    Huang, Jiefang
    Liu, Yongnian
    Yu, Hongshuang
    Jin, Min
    Hu, Shaoyan
    Tong, Qing
    Ma, Anqi
    Jin, Jian
    Hexner, Elizabeth
    Fung, Henry
    Reshef, Ran
    Zhang, Yi
    Zhang, Yanyun
    BLOOD, 2017, 129 (20) : 2737 - 2748
  • [9] Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells
    Hashimoto, D
    Asakura, S
    Miyake, S
    Yamamura, T
    Van Kaer, L
    Liu, C
    Tanimoto, M
    Teshima, T
    JOURNAL OF IMMUNOLOGY, 2005, 174 (01): : 551 - 556
  • [10] Alloreactive T-cells in graft-versus-host disease are recruited to target tissues by inflammatory TH1 cytokines
    Baker, J.
    Beilhack, A.
    Wai, L.
    Schulz, S.
    Kiesel, C.
    Baker, E.
    Landan, G.
    Herman, E.
    Nishimura, R.
    Beilhack, G. F.
    Olson, J.
    Negrin, R.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S45 - S45
12345